lncRNA ENST 933在乳腺癌中的作用及其机制研究

邓钰梅; 陈俊霞

doi:10.16016/j.2097-0927.202401022

您当前的位置：

首页 >

文章列表页 >

lncRNA ENST 933在乳腺癌中的作用及其机制研究

基础医学 | 更新时间：2026-01-09

- lncRNA ENST 933在乳腺癌中的作用及其机制研究
- Role of long non-coding RNA ENST 933 in breast cancer and its underlying mechanism
- 陆军军医大学学报 2024年46卷第14期页码：1676-1694
- 作者机构：
  
  400016 重庆，重庆医科大学分子医学与肿瘤研究中心
- 作者简介：
  
  [陈俊霞，E-mail: chjunxia@126.comCHEN Junxia, E-mail: chjunxia@126.com
- 基金信息：
  
  国家自然科学基金面上项目(82173170)
- DOI：10.16016/j.2097-0927.202401022
  中图分类号： R394.3;R730.23;R737.9
- 收稿：2024-01-05，
  
  修回：2024-03-09，
  
  纸质出版：2024-07-30
- 稿件说明：
移动端阅览
邓钰梅, 陈俊霞. lncRNA ENST 933在乳腺癌中的作用及其机制研究[J]. 陆军军医大学学报, 2024,46(14):1676-1694.

Yumei DENG, Junxia CHEN. Role of long non-coding RNA ENST 933 in breast cancer and its underlying mechanism[J]. Journal of Army Medical University, 2024, 46(14): 1676-1694.
邓钰梅, 陈俊霞. lncRNA ENST 933在乳腺癌中的作用及其机制研究[J]. 陆军军医大学学报, 2024,46(14):1676-1694. DOI： 10.16016/j.2097-0927.202401022.

Yumei DENG, Junxia CHEN. Role of long non-coding RNA ENST 933 in breast cancer and its underlying mechanism[J]. Journal of Army Medical University, 2024, 46(14): 1676-1694. DOI： 10.16016/j.2097-0927.202401022.

摘要

目的

探讨长链非编码RNA ENST00000579933(简称lncRNA ENST 933)对乳腺癌(breast cancer，BC)发展的调控机制。

方法

通过实时荧光定量聚合酶链反应(real-time fluorescent quantitative polymerase chain reaction，RT-qPCR)检测lncRNA ENST 933在BC组织和BC细胞系(MCF-7、MDA-MB-231、MDA-MB-453)中的表达；运用细胞计数试剂盒-8(cell counting kit-8，CCK-8)、克隆形成、EdU、Transwell、流式细胞仪、蛋白质印迹法(Western blot)、体内移植瘤实验检测lncRNA ENST 933和miR-588在BC细胞增殖、迁移、侵袭与周期中的作用；采用双荧光素酶报告基因、RNA免疫共沉淀实验、RT-qPCR、Western blot和挽救实验来评估lncRNA ENST 933、miR-588、真核起始因子6(eukaryotic initiation factor 6，EIF6)之间的互相作用。

结果

lncRNA ENST 933在BC组织和BC细胞系中表达均显著上调(

＜0.05)，过表达lncRNA ENST 933能够提升BC细胞增殖、迁移与侵袭能力，促进移植瘤生长，而敲低lncRNA ENST 933表达后BC的发展受到抑制，并导致细胞周期阻滞(

＜0.05)。miR-588在BC组织中表达明显下调，过表达miR-588可抑制BC细胞的增殖、迁移与侵袭(

＜0.05)。挽救实验结果表明lncRNA ENST 933可通过与miR-588进行竞争性结合，从而促进靶基因EIF6的表达。Western blot结果显示miR-588降低了AKT和mTOR的磷酸化水平(

＜0.05)。

结论

lncRNA ENST 933可通过调控miR-588/EIF6轴促进BC的进展。

Abstract

Objective

To investigate the regulatory mechanism of long non-coding RNA (lncRNA) ENST00000579933 (hereinafter referred to as lncRNA ENST 933) on the development of breast cancer (BC).

Methods

The expression level of lncRNA ENST 933 in BC tissues as well as in BC cell lines (MCF-7

MDA-MB-231

MDA-MB-453) was detected by fluorescence-based real-time quantitative polymerase chain reaction RT-qPCR. The effects of lncRNA ENST 933 and miR-588 on the proliferation

migration

invasion and cell cycle in BC were determined using CCK-8 assay

clone formation assay

EdU

Transwell assay

flow cytometry

Western blotting and

in vivo

transplantation tumor assay. Finally

dual luciferase reporter gene

RNA immunoprecipitation assay

RT-qPCR

Western blotting and rescue assay were used to evaluate the interactions among lncRNA ENST 933

miR-588

and eukaryotic initiation factor 6 (EIF6).

Results

The expression of lncRNA ENST 933 was up-regulated in both BC tissues and BC cell lines (

0.05). Overexpression of lncRNA ENST 933 could enhance the proliferation

migration and invasion abilities of BC cells and promote

the growth of transplanted tumors

while knockdown of lncRNA ENST 933 resulted in inhibited development of BC and arrested cell cycle (

0.05). The expression of miR-588 was obviously down-regulated in BC tissues

and its overexpression inhibited cell proliferation

migration and invasion abilities in the BC cells (

0.05). Moreover

the results of rescue assay indicated that lncRNA ENST 933 promoted the expression of target gene EIF6 by competitively binding with miR-588. Western blotting revealed that miR-588 decreased the phosphorylation of AKT and mTOR (

0.05).

Conclusion

lncRNA ENST 933 promotes the progression of BC by modulating the miR-588/EIF6 axis.

关键词

Keywords

references

XU J, WU K J, JIA Q J, et al . Roles of miRNA and lncRNA in triple-negative breast cancer[J ] . J Zhejiang Univ Sci B, 2020, 21(9): 673-689. DOI: 10.1631/jzus.B1900709.

CUI Y, FAN Y H, ZHAO G C, et al . Novel lncRNA PSMG3-AS1 functions as a miR-143-3p sponge to increase the proliferation and migration of breast cancer cells[J ] . Oncol Rep, 2020, 43(1): 229-239. DOI: 10.3892/or.2019.7390.

MIRZAEI S, GHOLAMI M H, HUSHMANDI K, et al . The long and short non-coding RNAs modulating EZH2 signaling in cancer[J ] . J Hematol Oncol, 2022, 15(1): 18. DOI: 10.1186/s13045-022-01235-1.

HUANG Z K, MA Y Y, ZHANG P P, et al . Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lungadenocarcinoma[J ] . Anticancer Drugs, 2020, 31(1): 44-54. DOI: 10.1097/CAD.0000000000000831.

HU J, HUANG H H, XI Z H, et al . LncRNA SEMA3B-AS1 inhibit s breast cancer progression by targeting miR-3940/KLLN axis[J ] . Cell Death Dis, 2022, 13(9): 800. DOI: 10.1038/s41419-022-05189-7.

ZHU J X, DAI H, LI X, et al . LncRNA TRG-AS1 inhibits bone metastasis of breast cancer by the miR-877-5p/WISP2 axis[J ] . Pathol Res Pract, 2023, 243: 154360. DOI: 10.1016/j.prp.2023.154360.

SUN J, LI X H, YIN J, et al . Long non coding RNA COX10-DT promotes the progression of breast cancer via the COX10-DT/miR-206/BDNF axis[J ] . Biochem Biophys Res Commun, 2023, 639: 46-53. DOI: 10.1016/j.bbrc.2022.11.057.

YU R, ZHAO R R, SUN X P, et al . MicroRNA-588 regulates the invasive, migratory and vasculogenic mimicry-forming abilities of hypoxic glioma cells by targeting ROBO1[J ] . Mol Biol Rep, 2023, 50(2): 1333-1347. DOI: 10.1007/s11033-022-08063-z.

LIU Z K, MO H Y, SUN L K, et al . Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway[J ] . Cancer Sci, 2020, 111(11): 4118-4128. DOI: 10.1111/cas.14631.

SUN L P, LIU S G, WANG X P, et al . eIF 6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway[J ] . J Transl Med, 2021, 19(1): 216. DOI: 10.1186/s12967-021-02877-4.

KLINGE C M. Non-coding RNAs in breast cancer: intracellular and intercellular communication[J]. Noncoding RNA, 2018, 4(4): 40. DOI: 10.3390/ncrna4040040.

XIU Y, CAO S N, JIANG R, et al . lncRNA LINC01315 promotes malignancy of triple-negative breast cancer and predicts poor outcomes by modulating microRNA-876-5p/GRK5[J ] . Bioengineered, 2022, 13(4): 10001-10009. DOI: 10.1080/21655979.2022.2062536.

CAO W, LIU X J, SU W J, et al . LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP)[J ] . Bioengineered, 2022, 13(2): 4573-4586. DOI: 10.1080/21655979.2022.2031402.

HE C, FU Y, CHEN Y, et al . Long non-coding RNA SNHG8 promotes autophagy as a ceRNA to upregulate ATG7 by sponging microRNA-588 in colorectal cancer[J ] . Oncol Lett, 2021, 22(2): 577. DOI: 10.3892/ol.2021.12838.

ZHAO J, LI X D, WANG M, et al . Circular R NA ABCB10 contributes to laryngeal squamous cell carcinoma (LSCC) progression by modulating the miR-588/CXCR4 axis[J ] . Aging, 2021, 13(10): 14078-14087. DOI: 10.18632/aging.203025.

YU T, LIANG S, MA T H, et al . Downregulation of miR-588 is associated with tumor progression and unfavorable prognosis in patients with osteosarcoma[J ] . Exp Ther Med, 2021, 21(6): 592. DOI: 10.3892/etm.2021.10024.

YU M, ZHANG X, LI H, et al . MicroRNA-588 is downregulated and may have prognostic and functional roles in human breast cancer[J ] . Med Sci Monit, 2017, 23: 5690-5696. DOI: 10.12659/msm.905126.

MILUZIO A, OLIVETO S, PESCE E, et al . Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo [J ] . Oncotarget, 2015, 6(35): 37471-37485. DOI: 10.18632/oncotarget.5462..

GATZA M L, SILVA G O, PARKER J S, et al . An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer[J ] . Nat Genet, 2014, 46(10): 1051-1059. DOI: 10.1038/ng.3073.

LIN J X, YU X H, XIE L P, et al . eIF6 promotes colorectal cancer proliferation and invasion by regulating AKT-related signaling pathways[J ] . J Biomed Nanotechnol, 2019, 15(7): 1556-1567. DOI: 10.1166/jbn.2019.2792.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Heregulin-β1诱导硬脂酰辅酶A去饱和酶1促进乳腺癌细胞的增殖、迁移和侵袭

长链非编码ATB通过抑制miR-200c的表达促进乳腺癌细胞的侵袭转移

HYAL1基因过表达对乳腺癌细胞迁移能力和血管生成能力及增殖的影响

MiR-616在骨肉瘤中的表达及对其细胞增殖、凋亡、迁移侵袭的作用

β-arrestin1在口腔鳞状细胞癌中的表达及其对细胞增殖、迁移、侵袭的作用